David A. D’Alessio

34.1k citations
255 papers · 23.5k · 10 hit papers · h-index 79

Impact in

Papers in

David A. D’Alessio

250 papers receiving 23.0k citations

David A. D’Alessio's Hit Papers

Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics 2023 · 141 citations
1410+7+15Years since publication50010001.5k2.0k2.5k

Peers

David A. D’Alessio
Comparison fields: 5 of 163
  • Endocrinology, Diabetes and Metabolism 10.7k
  • Endocrine and Autonomic Systems 3.9k
  • Physiology 5.7k
  • Surgery 6.9k
  • Nutrition and Dietetics 1.8k
Replace Frank Reimann with:
Frank Reimann United Kingdom
Robert S. Sherwin United States
Fiona M. Gribble United Kingdom
Richard E. Pratley United States
Philippe Froguel France
Bo Åhrén Sweden
Peter J. Havel United States
Josephine M. Egan United States
Felipe F. Casanueva Spain
Michael Stümvoll Germany
David A. D’Alessio relative to Frank Reimann United Kingdom Frank Reimann's profile →
Citations per field
00.5×1.5×
Frank Reimann · 1×
Citations per year

Countries citing papers authored by David A. D’Alessio

Since Specialization
Citations

This map shows the geographic impact of David A. D’Alessio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. D’Alessio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. D’Alessio more than expected).

Fields of papers citing papers by David A. D’Alessio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. D’Alessio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. D’Alessio. The network helps show where David A. D’Alessio may publish in the future.

Co-authors

The 25 scholars most cited alongside David A. D’Alessio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. D’Alessio Line = papers co-authored together David A. D’Alessio links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 255 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Hit paper breakdown →
20182699
2
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Hit paper breakdown →
20181119
3
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Hit paper breakdown →
2019853
4
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
Hit paper breakdown →
2018638
5
A Randomized Trial Comparing a Very Low Carbohydrate Diet and a Calorie-Restricted Low Fat Diet on Body Weight and Cardiovascular Risk Factors in Healthy Women
Hit paper breakdown →
2003612
6 2003431
7 2009400
8
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Hit paper breakdown →
2015380
9 1990376
10
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Hit paper breakdown →
2019353
11
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
Hit paper breakdown →
2020340
12 2008337
13 2014327
14 1987304
15 2007278
16 2008270
17 2005267
18 2002266
19 2005260
20 2010254

About David A. D’Alessio

David A. D’Alessio is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Physiology, Endocrine and Autonomic Systems and Molecular Biology, having authored 255 papers that have together received 23.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (106 papers), Pancreatic function and diabetes (73 papers), Regulation of Appetite and Obesity (53 papers), Diet and metabolism studies (45 papers), Bariatric Surgery and Outcomes (30 papers), Diabetes Management and Research (29 papers), Metabolism, Diabetes, and Cancer (20 papers) and Adipose Tissue and Metabolism (18 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (10.7k citations), Endocrine and Autonomic Systems (3.9k citations), Physiology (5.7k citations), Surgery (6.9k citations) and Nutrition and Dietetics (1.8k citations). David A. D’Alessio has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Randy J. Seeley, Stephen C. Woods, John B. Buse, Deborah J. Wexler, Melanie J. Davies, Geltrude Mingrone, Απόστολος Τσάπας, Peter Rossing, Darleen A. Sandoval and Walter N. Kernan. Their work appears in journals such as Diabetes, The Journal of Clinical Endocrinology & Metabolism, American Journal of Physiology-Endocrinology and Metabolism, Endocrinology and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact